| Tag | Content |
|---|
EnhancerAtlas ID | HS108-35876 | Organism | Homo sapiens | Tissue/cell | K562 | Coordinate | chr6:150550660-150551940 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35859 | chr6:150550432-150551829 | HMEC |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH06I150229 | chr6 | 150551001 | 150551150 |
| Enhancer Sequence | TTGGGATTTG GGTAAAAAAA TAAATTAGCC CAAGAACAAT GGACTGAATC TATAAAATAG 60
ATTAATGGGA CTTCGCTCAC AGTGGAACAA ATTACTATTT AAAGGCAGAT AGTCTAGAAA 120
ATAAGTGGAC AAACATCGTG TCAGTGGTTT TAAGTTAAAG GAGGGGGAAA AAACAGGATG 180
TAGTTAAGAC CTTCAGGAAT TTATGTTGAC AGAAGTCATT TTAACAACAG CAGCCACAAA 240
CCCTTACCCA TAACAGATCC ATAAGCCTCC TTTCAGATAA TGAAAAATAG GATCAGTTCT 300
GGTGCGCCAT GCCAGCAAAT GAACCTCTCG AAAGATAAAA ACAACCCCTG CCCCCCAAAA 360
AGAAGGGGGA AATTAAATGT GTCAGTGGTG AGTGATGGTG GGCGAGAGGG CTTGCTGTGG 420
AGCTGATTCA TGCCTGTAAC TTCCAGGAGC AAATCCCCGT GTCACACTGA GTTGGGGAAC 480
ACCCCAAAGC TGAGCTCATC AGTACTGATT CAACTGCCTG CCTGTTTGCC CTCATCCAGG 540
AGTTTTCAGT GTGATTTTTA AATGCCTAGC TGGTTCTTTG GGTGAGGACA TTTTGCCATT 600
TGGAACAATT TGCAGGTGTT ATCCTCACCT TTTCCAAGAG GCACACACCA CCTGCCCATT 660
TTCCTCACTC ATCTAAACTT TGGGCATCTG GAAATTCTTC CCTTCCCACC ACCCGCTTCA 720
CACTTTGCCT GCTTCCCACC CATCTGCTAA TGTCAGGCTT TTTGGAAGAA GTGTCGGGTA 780
GCTGCTTCAC AGGAAACTCA CCATGGAGTT GACTCAATTT GCTGTAAGTT GGCAGCCAGC 840
CCCCAGGCCC AGGGCAGATG GCTCCTGTGA ATGTGCACCT TGAAGGAAGT AACTGATCAG 900
GGGCACAAAG AGGAGGCAAC ACGTGGGGAG TTGCATGGCC CATGTGGATC CCAGCCTTTG 960
GAATCCTCAT CTGCTGTTTC TCTCCCGTCC CCCCACCCTC TGCGTAGGGA ATGGATGGGT 1020
CTTTTTTTGT TGTTGTTGTT GTTTGTTTGT CTGTTTTTGG AAAAGCTGGG TGAGCATCCG 1080
CAGTTCTTCT GGGCACCCTT TATTAGAGCT TGCGTAATGT ATACAATCAC TGCCATTGGT 1140
GAGACTGTTT CCTGAGCAGG GATTTTAAGC ATTTCTTCTT TTGTCAGGAA ATATTTCCAA 1200
TCCAAGGGCC ACTGCATAAT ATCCATTTAT CTCGTTTAGC TTTTTAAATG GCTCAAAATG 1260
CTTAAAAGAA GGACATAAGT 1280
|
| |
|
|
|
